Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of HEMOSTEMIX INC.
No Price
Closing Price XTSX 28.04.2026:
0,07 CAD
28.04.2026 20:00
Current Prices from HEMOSTEMIX INC.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
HMTXF
USD
28.04.2026 20:00
0,05 USD
0,00 USD
TSX-V
HEM.V
CAD
28.04.2026 17:28
0,07 CAD
-0,005 CAD
-7,14 %
Share Float & Liquidity
Free Float79,25 %
Shares Float149,38 M
Shares Outstanding188,49 M
Company Profile for HEMOSTEMIX INC. Share
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
